Stocks
Quest Diagnostics IncorporatedDGX
NYSEHealthcareDiagnostics & Research$199.70-0.59%
A leading provider of diagnostic testing, information, and services, Quest Diagnostics operates one of the largest clinical laboratories in the U.S. Investors monitor the company for its role in preventive care, chronic disease management, and COVID-19 testing capabilities. The firm's scale and data analytics offerings position it as a key player in lab-based diagnostics.
Market Cap: $22.2B52W Range: $157.20 – $213.50
Congressional Interest in Quest Diagnostics Incorporated (DGX)
9 members of Congress have disclosed 50 trades in Quest Diagnostics Incorporated (DGX), a Healthcare company. The buy/sell breakdown shows 27 purchases versus 23 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
9
Buys
27
Sells
23
Who in Congress Is Trading DGX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-06-17 | MIKE KELLY | sell | $1K – $15K |
| 2019-06-17 | MIKE KELLY | buy | $1K – $15K |